In the article published by Copland et al entitled “BMS-214662 potently induces apoptosis of chronic myeloid leukemia stem and progenitor cells and synergizes with tyrosine kinase inhibitors,” which appeared in the March 1, 2008, issue of Blood (Volume 111:2843–2853), reference 41 was incorrect. The correct reference is the following:

Gomez-Benito M, Marzo I, Anel A, Naval J. Farnesyltransferase inhibitor BMS-214662 induces apoptosis in myeloma cells through PUMA up-regulation, Bax and Bak activation and Mcl-1 elimination. Mol Pharmacol. 2005;67:1991-1998.